Last Price
1.39
Today's Change
+0.049 (3.62%)
Day's Change
1.28 - 1.39
Trading Volume
1,459,178
Market Cap
2 Million
Shares Outstanding
157 Million
Avg Volume
2,504,418
Avg Price (50 Days)
1.87
Avg Price (200 Days)
1.73
PE Ratio
-1.40
EPS
-0.01
Earnings Announcement
28-Apr-2026
Previous Close
1.35
Open
1.30
Day's Range
1.2875 - 1.399
Year Range
1.076 - 5.5
Trading Volume
1,459,178
1 Day Change
3.63%
5 Day Change
-0.07%
1 Month Change
-9.74%
3 Month Change
-39.17%
6 Month Change
-17.71%
Ytd Change
-66.69%
1 Year Change
-66.29%
3 Year Change
-79.65%
5 Year Change
-79.27%
10 Year Change
-79.27%
Max Change
-79.27%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Roquefort Therapeutics plc operates as a biotechnology research company. The company engages in the research and development of drugs targeting Midkine, a circulating growth factor protein and pro-inflammatory mediator for the treatment of cancer. Roquefort Therapeutics plc was incorporated in 2020 and is headquartered in London, the United Kingdom.
{uid}
{comment}
Just now